Literature DB >> 7723277

New pancreas cancers cell lines that represent distinct stages of ductal differentiation.

M R Vilá1, J Lloreta, M H Schüssler, G Berrozpe, S Welt, F X Real.   

Abstract

BACKGROUND: Most available pancreas cancer cell lines have been in culture for long periods of time, have not been extensively characterized from the cell biology standpoint, or lack differentiated properties. EXPERIMENTAL
DESIGN: We have established four new cell lines from ductal pancreatic cancers (IMIM-PC-1, IMIM-PC-2, SK-PC-1, and SK-PC-3). The phenotype and functional properties of the cell lines were analyzed using ultrastructural methods, antibodies detecting cytokeratin polypeptides and mucin epitopes, and cDNA probes of epithelial differentiation markers.
RESULTS: IMIM-PC-2 and SK-PC-1 cells grow as a polarized monolayer, form domes, and express all CK polypeptides typical of simple epithelia and the MUC1 mucin. IMIM-PC-1 and SK-PC-3 are morphologically less differentiated and express low or undetectable levels of CK7 and MUC1. By Northern blotting, we found that SK-PC-1 and SK-PC-3 cells express carbonic anhydrase II and that the cystic fibrosis transmembrane regulator was undetectable in the four lines. Secretin induces a marked stimulation of cAMP levels in all cell lines except for SK-PC-3. Cytogenetic analysis demonstrates their human origin.
CONCLUSIONS: Levels of CK7 and MUC1 are associated with less differentiated cultures. The new cell lines should be useful tools to study the cell biology of exocrine pancreas cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7723277

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  15 in total

1.  Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway.

Authors:  Malte Buchholz; Alexandra Schatz; Martin Wagner; Patrick Michl; Thomas Linhart; Guido Adler; Thomas M Gress; Volker Ellenrieder
Journal:  EMBO J       Date:  2006-07-27       Impact factor: 11.598

2.  Role of UEV-1, an inactive variant of the E2 ubiquitin-conjugating enzymes, in in vitro differentiation and cell cycle behavior of HT-29-M6 intestinal mucosecretory cells.

Authors:  E Sancho; M R Vilá; L Sánchez-Pulido; J J Lozano; R Paciucci; M Nadal; M Fox; C Harvey; B Bercovich; N Loukili; A Ciechanover; S L Lin; F Sanz; X Estivill; A Valencia; T M Thomson
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

3.  Lysosomal alpha-glucosidase: cell-specific processing and altered maturation in HT-29 colon cancer cells.

Authors:  C Francí; G Egea; R Arribas; A J Reuser; F X Real
Journal:  Biochem J       Date:  1996-02-15       Impact factor: 3.857

4.  A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile.

Authors:  Paolo Monti; Federica Marchesi; Michele Reni; Alessia Mercalli; Valeria Sordi; Alessandro Zerbi; Giampaolo Balzano; Valerio Di Carlo; Paola Allavena; Lorenzo Piemonti
Journal:  Virchows Arch       Date:  2004-07-17       Impact factor: 4.064

5.  WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer.

Authors:  Heidi Griesmann; Stefanie Ripka; Moritz Pralle; Volker Ellenrieder; Sandra Baumgart; Malte Buchholz; Christian Pilarsky; Daniela Aust; Thomas M Gress; Patrick Michl
Journal:  Neoplasia       Date:  2013-01       Impact factor: 5.715

6.  A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform.

Authors:  Bence Sipos; Simone Möser; Holger Kalthoff; Virag Török; Matthias Löhr; Günter Klöppel
Journal:  Virchows Arch       Date:  2003-04-12       Impact factor: 4.064

7.  The developmental transcription factor Gata4 is overexpressed in pancreatic ductal adenocarcinoma.

Authors:  Matthew S Karafin; Christopher T Cummings; Baojin Fu; Christine A Iacobuzio-Donahue
Journal:  Int J Clin Exp Pathol       Date:  2009-08-30

8.  Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met.

Authors:  R Paciucci; M R Vilá; T Adell; V M Díaz; M Torà; T Nakamura; F X Real
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

9.  Comprehensive analysis of cellular galectin-3 reveals no consistent oncogenic function in pancreatic cancer cells.

Authors:  Alexander Hann; Anja Gruner; Ying Chen; Thomas M Gress; Malte Buchholz
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

10.  VE-cadherin expression and clustering maintain low levels of survivin in endothelial cells.

Authors:  Monica Iurlaro; Fabio Demontis; Monica Corada; Lucia Zanetta; Cristopher Drake; Manuela Gariboldi; Sandra Peiro; Amparo Cano; Pilar Navarro; Anna Cattelino; Simona Tognin; Pier Carlo Marchisio; Elisabetta Dejana
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.